Lead Pharma
PrivateLast Round
Buyout/LBO
Mar 6, 2026
Total Funding Raised
$11.84M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lead Pharma operates in Healthcare & Life Sciences and is based in Deventer. Its latest recorded funding round was a Strategic round in November 2020.
Lead Pharma is a biopharmaceutical company that discovers and develops innovative small-molecule therapies for the treatment of autoimmune diseases, metabolic diseases, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lead Pharma Comparables
Compare Lead Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phenex Pharmaceuticals AG | 81% | |
| Odyssey Therapeutics | 78% | |
| Evotec | 74% |
For institutional investors. Book with your work email.
Lead Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Mar 6, 2026 | ||||
| Strategic | Nov 16, 2020 | ||||
| Strategic | Feb 18, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lead Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 819 Capital Partners | Buyout/LBO |
| Waterman Ventures | Buyout/LBO |
| East Netherlands Development Agency (Oost NL) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 121% MoM, reaching 1.5K.
- Mar 3, 2026
Monthly visitors increased 420% MoM.
For institutional investors. Book with your work email.
Lead Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lead Pharma's valuation, stock price, and market status.
Is Lead Pharma a public or private company?
Lead Pharma is a private company.
What is the current stock price of Lead Pharma?
Lead Pharma is a private company, so its shares have no public market price. Caplight tracks Lead Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lead Pharma worth (valuation)?
Valuation information for Lead Pharma is not publicly available.
Can I buy Lead Pharma stock?
Lead Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lead Pharma's last funding round?
Lead Pharma's most recent funding round was Buyout/LBO on March 6, 2026.
Who are the main investors in Lead Pharma?
Key investors in Lead Pharma include 819 Capital Partners.
Will Lead Pharma IPO soon?
No public IPO plans have been announced for Lead Pharma.
How can I track Lead Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Lead Pharma's shares on secondary markets.